Quantifying FDG uptake to diagnose cardiac device infections: When and how should we do it?
Non-Invasive Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology, Brigham and Women's Hospital, 75 Francis St, Boston, MA, 02115, USA. rblankstein@partners.org.|Harvard Medical School, Boston, MA, USA. rblankstein@partners.org.
Ron
R
Blankstein
Section of Cardiovascular Medicine, Departments of Medicine and Radiology, Yale University School of Medicine, New Haven, CT, USA.
Edward J
EJ
Miller
D019788:Fluorodeoxyglucose F18; D006331:Heart Diseases; D006801:Humans; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18